» Articles » PMID: 24206230

Advanced Technologies for Studying Circulating Tumor Cells at the Protein Level

Abstract

Metastasis is the main cause of cancer death. As the tumor progresses, cells from the primary tumor site are shed into the bloodstream as circulating tumor cells (CTCs). Eventually, these cells colonize other organs and form distant metastases. It is therefore imperative that we gain a better understanding of the biological characteristics of CTCs for development of novel treatment modalities to minimize metastasis-associated cancer deaths. In recent years, rapid developments in technologies for the study of CTCs have taken place. We now have a variety of tools for the isolation and examination of CTCs which were not available before. This review introduces some commonly used protein markers in CTC investigations and summarizes a few advanced technologies which have been successfully applied for studying CTC biology at the protein level.

Citing Articles

Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications.

Yadav A, Kumar A, Siddiqui M World J Clin Oncol. 2022; 12(12):1169-1181.

PMID: 35070736 PMC: 8716996. DOI: 10.5306/wjco.v12.i12.1169.


Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

Chen J, Ho H, Lichterman J, Lu Y, Zhang Y, Garcia M Cancer. 2015; 121(18):3240-51.

PMID: 25975562 PMC: 4560974. DOI: 10.1002/cncr.29455.